| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mallinckrodt plc | Director | Ordinary Shares | 795 | $68,768 | $86.50 | 31 Jul 2025 | Direct |
| Keenova Therapeutics plc | Director | Restricted Stock Units | 8,866 | 23 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465926019926-langlois-sophia-d-2026-02-23 | Keenova Therapeutics plc | 23 Feb 2026 | 1 | $0 | 4 | Director | 25 Feb 2026, 20:55 |
| /report/000110465925079947-langlois-sophia-d-2025-08-14 | Mallinckrodt plc | 14 Aug 2025 | 1 | $0 | 4 | Director | 18 Aug 2025, 21:05 |
| /report/000110465925073780-langlois-sophia-d-2025-07-31 | Mallinckrodt plc | 31 Jul 2025 | 0 | $0 | 3 | Director | 04 Aug 2025, 20:45 |